Challenges to Design and Develop of DNA Aptamers for Protein Targets. II. Development of the Aptameric Affinity Ligands Specific to Human Plasma Coagulation Factor VIII Using SEC-SELEX.

MLA

Vahidi, Hossein, et al. “Challenges to Design and Develop of DNA Aptamers for Protein Targets. II. Development of the Aptameric Affinity Ligands Specific to Human Plasma Coagulation Factor VIII Using SEC-SELEX.” Iranian Journal of Pharmaceutical Research, vol. 16, no. 2, Spring 2017, pp. 734–41. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=124017694&authtype=sso&custid=ns315887.

APA

Vahidi, H., Nafissi-Varcheh, N., Kazemi, B., Aboofazeli, R., Shahhosseini, S., & Tabarzad, M. (2017). Challenges to Design and Develop of DNA Aptamers for Protein Targets. II. Development of the Aptameric Affinity Ligands Specific to Human Plasma Coagulation Factor VIII Using SEC-SELEX. Iranian Journal of Pharmaceutical Research, 16(2), 734–741.

Chicago

Vahidi, Hossein, Nastaran Nafissi-Varcheh, Bahram Kazemi, Reza Aboofazeli, Soraya Shahhosseini, and Maryam Tabarzad. 2017. “Challenges to Design and Develop of DNA Aptamers for Protein Targets. II. Development of the Aptameric Affinity Ligands Specific to Human Plasma Coagulation Factor VIII Using SEC-SELEX.” Iranian Journal of Pharmaceutical Research 16 (2): 734–41. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=124017694&authtype=sso&custid=ns315887.